TytoCare Revenue and Competitors

Location

$156.7M

Total Funding

Estimated Revenue & Valuation

  • TytoCare's estimated annual revenue is currently $83.8M per year.(i)
  • TytoCare received $9.0M in venture funding in January 2019.
  • TytoCare's estimated revenue per employee is $313,750
  • TytoCare's total funding is $156.7M.

Employee Data

  • TytoCare has 267 Employees.(i)
  • TytoCare grew their employee count by 4% last year.

TytoCare's People

NameTitleEmail/Phone
1
Area VPReveal Email/Phone
2
COO & Co-FounderReveal Email/Phone
3
CEO, Co-FounderReveal Email/Phone
4
VP, Customer Strategy & GrowthReveal Email/Phone
5
VP Global Customer SuccessReveal Email/Phone
6
VP R&DReveal Email/Phone
7
VP Hardware & InnovationReveal Email/Phone
8
VP OperationsReveal Email/Phone
9
VP ProductReveal Email/Phone
10
VP PeopleReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$274M1398N/AN/AN/A
#2
$159.3M472-4%N/AN/A
#3
$1.3M15-6%N/AN/A
Add Company

What Is TytoCare?

TytoCare is transforming primary care by putting health in the hands of consumers. We seamlessly connect people to clinicians to provide the best home examination and diagnosis solutions. TytoCare's mission is to delight consumers and clinicians alike by delivering easy, affordable and high quality telehealth visits, complete with medical exams, all from the comfort of home. TytoCare is introducing two telehealth products. TytoHome is a remote examination tool and telehealth platform that connects consumers to clinicians to enable a comprehensive medical examination (ears, nose, throat, lungs, heart and temperature) anytime and anywhere. TytoPro is a professional examination tool and telehealth platform that connects medical practitioners to each other to share remote exam data, conduct a specialist consultation, or get a second opinion. TytoPro can also be used in-office to share images with patients to explain diagnoses and motivate treatments. TytoCare was founded by Dedi Gilad, Ofer Tzadik and industry experts in 2012 with a vision to put health in the hands of the consumer. The Company has received over $18 million in funding from investors including Walgreens, Cambia Health Solutions, OrbiMed, Fosun Pharma, LionBird, and Teuza. For more information visit www.tytocare.com.

keywords:N/A

$156.7M

Total Funding

267

Number of Employees

$83.8M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TytoCare News

2022-04-20 - TytoCare's on-demand medical exam capabilities find use in ...

Through TytoCare's FDA-cleared handheld examination kit, users can perform comprehensive physical exams of the heart, skin, ears, throat,...

2022-04-13 - African Healthtech Company mPharma Partners with ...

TytoCare is a telehealth company using AI to transform primary care by putting health in the hands of consumers. TytoCare seamlessly connects...

2022-04-13 - mPharma partners TytoCare to introduce telehealth to ...

TytoCare brings this vision one step further by enabling remote physical exams of the heart, skin, ears, throat, abdomen, and lungs, and...

2021-10-18 - HLTH21: TytoCare Launches Enhanced Telehealth Video Capabilities Powered by Amazon Chime

What You Should Know: – Today at HLTH21, TytoCare launched an expansion of its video capabilities, including enhanced video quality, multi-party calls, and the ability for clinicians to conduct remote visits on any tablet, including iPads. – The enhanced video capabilities include top-of-the-l ...

2021-08-17 - Prisma Health Partners with TytoCare to Expand Telehealth Offerings

NEW YORK, Aug. 17, 2021 /PRNewswire/ -- TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams today announced its partnership with Prisma Health, the largest healthcare system in South Carolina. The in ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$58.6M267-14%$78M
#2
$59.3M26714%N/A
#3
$42.6M267N/AN/A
#4
$73.4M267-3%N/A
#5
$41.1M267-12%N/A

TytoCare Funding

DateAmountRoundLead InvestorsReference
2018-01-30$25.0MUndisclosedPing An Global Voyager FundArticle
2019-01-17$9.0MUndisclosedSanford HealthArticle